Le Lézard
Classified in: Health, Business
Subjects: SCZ, CXP, DEI

Assisted Living Locators Reaches Remarkable Milestone with 150th Franchise Opening


SCOTTSDALE, Ariz. , Jan. 17, 2024 /PRNewswire/ -- Assisted Living Locators, a leading senior placement and referral service and member of Evive Brands, proudly announces the opening of its 150th franchise in Southwest Metro Atlanta, GA, marking a significant milestone in the company's nationwide expansion. This achievement comes on the heels of last year's celebration of the company's 20th anniversary, further demonstrating its continuous growth in the senior care industry.

The new Forest Park franchise is owned by Brian Sullivan, who brings a fresh perspective and a deep commitment to providing compassionate care to seniors in the Georgia community. "Opening the 150th Assisted Living Locators franchise is not just a personal accomplishment but an indication of the brand's strength and the increasing demand for senior care services," said Sullivan.

Angela Olea, RN, Founder and Brand President of Assisted Living Locators, remarked on this landmark achievement: "Our success over these two decades reflects the trust our franchisees have in us. Our presence in 39 states plus DC and the potential for 150 more franchises highlights the strength of our team, our effective business model, and our steadfast dedication to providing exceptional services to seniors and their loved ones."

The demand for services like Assisted Living Locators is set to surge as U.S. senior population estimates point to a near doubling by 2060. With such demographics in view, Ryan Parsons CEO of Evive Brands, Assisted Living Locators' parent company, expressed optimism about the brand's future. "Our exponential growth responds to real community needs. As the elderly population continues to grow, our commitment remains strong to broaden our services and touch more lives."

Setting it apart, Assisted Living Locators is the sole senior placement agency boasting systemwide dementia care certification. Its distinct service model and expansive franchise network prime it to meet the rising demand for premium elderly care services in the forthcoming years.

Assisted Living Locators, under the Evive Brands umbrella, offers a comprehensive range of care options for seniors and families, guiding them through top-tier in-home care, diverse retirement options, assisted living, and memory care. The brand has been recognized in Entrepreneur's "Franchise500®" and distinguished as a Top Senior Care Franchise by Franchise Business Review. For more information, visit  www.assistedlivinglocators.com/franchise.

Media Contact: Rhonda Grundemann, 602-739-8810, [email protected].

SOURCE Assisted Living Locators


These press releases may also interest you

at 07:35
Gossamer Bio, Inc. ("Gossamer") , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A ("Chiesi Group"), an...

at 07:30
Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief...

at 07:30
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company's Tigris trial, a Phase 3 follow-on study evaluating the use of...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a...

at 07:30
Carisma Therapeutics Inc.  ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will...

at 07:30
Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that it will report its financial results for the first quarter ended March  31, 2024 after the market close on...



News published on and distributed by: